The few numbers of BRCA1 MBCs in our cohort precludes extensive clinicopathological analysis, however, in contrast and unlike tumours seen in BRCA1 female carriers [27,51], cancers of medullary/basal cell phenotype in BRCA1 males has not been reported in the literature and was also not observed in our cohort of BRCA1 males. Here, BRCA1 is linked to neoplasm.